{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:15:38Z","timestamp":1783728938270,"version":"3.55.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    Pulmonary hypertension (PH) is one of the unfavorable clinical turning points in the natural history of heart failure with preserved ejection fraction (HFpEF). However, as it is identified as an independent predictor of worse prognosis, its true prevalence is uncertain. This review aims to investigate the pooled prevalence, associated risk factors, and characteristics of patients with PH-HFpEF. Systematic searches of 3 databases (PubMed, ScienceDirect, and Scopus) with citation searching were conducted. Studies conducting direct surveillance using echocardiography or catheterization for estimating the prevalence of PH-HFpEF patients (left ventricular ejection fraction \u226550%) were included. The Newcastle-Ottawa scale was used for quality assessment. RStudio was used for statistical analysis. This review comprises 11 studies (n = 1838 patients) that met the eligibility criteria. The pooled prevalence of PH-HFpEF was 0.63 (95% CI, 0.52\u20130.74). This value was robust based on leave-one-out and cumulative sample sensitivity analysis. Meta-regression revealed a significant relationship between PH prevalence and several associated factors, including history of coronary artery disease (\u03b2 = 0.50;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.0001), baseline female sex (\u03b2 = 0.49;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.0001), hypertension (\u03b2 = 0.49;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.0001), and diabetes (\u03b2 = 0.46;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.0001). Meta-analyses of echocardiography characteristics revealed that patients with PH-HFpEF have significantly worse diastolic function and more advanced left atrial remodeling compared to those without PH. In conclusion, PH was present in over half of HFpEF patients at baseline, with a history of coronary artery disease, female sex, hypertension, and diabetes significantly associated with greater susceptibility, emphasizing risk-based screening across these HFpEF phenotypes.\n                  <\/jats:p>","DOI":"10.1097\/crd.0000000000001235","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T20:02:09Z","timestamp":1775592129000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and Factors Associated With Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Meta-Regression"],"prefix":"10.1097","author":[{"given":"Christopher Daniel","family":"Tristan","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Central Java, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew Aldo","family":"Wijayanto","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Central Java, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlangga Masykur","family":"Kynaya","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Central Java, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico Ananda","family":"Budiono","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Central Java, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, Universitas Padjajaran, Bandung, West Java, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risalina","family":"Myrtha","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Medicine, Universitas Sebelas Maret, Surakarta, Central Java, Indonesia"},{"name":"Department of Cardiology and Vascular Medicine, Universitas Sebelas Maret Hospital, Sukoharjo, Central Java, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irnizarifka","family":"Irnizarifka","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Medicine, Universitas Sebelas Maret, Surakarta, Central Java, Indonesia"},{"name":"Department of Cardiology and Vascular Medicine, Universitas Sebelas Maret Hospital, Sukoharjo, Central Java, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Kris","family":"Dinarti","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Medicine, Universitas Gadjah Mada, Sleman, Special Region of Yogyakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bambang Budi","family":"Siswanto","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Medicine, Universitas Indonesia, Central Jakarta, Jakarta, Indonesia"},{"name":"Department of Cardiology and Vascular Medicine, National Cardiovascular Center Harapan Kita, West Jakarta, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hary Sakti","family":"Muliawan","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Medicine, Universitas Indonesia, Central Jakarta, Jakarta, Indonesia"},{"name":"Department of Cardiology and Vascular Medicine, Universitas Indonesia Hospital, Depok, West Java, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"R1-20260407","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution.","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"R3-20260407","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jacc.2020.06.069","article-title":"Pulmonary hypertension in HFpEF and HFrEF: JACC review topic of the week.","volume":"76","author":"Guazzi","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R4-20260407","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/HYPERTENSIONAHA.119.14330","article-title":"Pulmonary hypertension due to left heart disease.","volume":"75","author":"Al-Omary","year":"2020","journal-title":"Hypertension"},{"key":"R5-20260407","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardfail.2014.05.003","article-title":"Outcomes in World Health Organization group II pulmonary hypertension: mortality and readmission trends with systolic and preserved ejection fraction-induced pulmonary hypertension.","volume":"20","author":"Salamon","year":"2014","journal-title":"J Card Fail"},{"key":"R6-20260407","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1161\/CIR.0000000000001079","article-title":"Elucidating the clinical implications and pathophysiology of pulmonary hypertension in heart failure with preserved ejection fraction: a call to action: a science advisory from the American Heart Association.","volume":"146","author":"Brittain","year":"2022","journal-title":"Circulation"},{"key":"R7-20260407","doi-asserted-by":"crossref","first-page":"e70197","DOI":"10.1002\/clc.70197","article-title":"Prevalence of pulmonary hypertension in individuals with heart failure: a systematic review and meta-analysis.","volume":"48","author":"Khan","year":"2025","journal-title":"Clin Cardiol"},{"key":"R8-20260407","doi-asserted-by":"crossref","first-page":"e70016","DOI":"10.1002\/cesm.70016","article-title":"Single-arm interventional versus observational studies for assessing efficacy: a meta-epidemiological study.","volume":"3","author":"Chappell","year":"2025","journal-title":"Cochrane Evid Synth Methods"},{"key":"R9-20260407","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R10-20260407","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction. A community-based study.","volume":"53","author":"Lam","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R11-20260407","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.amjcard.2010.02.039","article-title":"Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction.","volume":"106","author":"Leung","year":"2010","journal-title":"Am J Cardiol"},{"key":"R12-20260407","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCHEARTFAILURE.110.958801","article-title":"Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction.","volume":"4","author":"Thenappan","year":"2011","journal-title":"Circ Heart Fail"},{"key":"R13-20260407","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jsha.2016.10.005","article-title":"Independent predictors of developing pulmonary hypertension in heart failure with reduced versus preserved ejection fraction.","volume":"29","author":"Roushdy","year":"2016","journal-title":"J Saudi Hear Assoc"},{"key":"R14-20260407","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/eurheartj\/ehy331","article-title":"Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease.","volume":"39","author":"Gorter","year":"2018","journal-title":"Eur Heart J"},{"key":"R15-20260407","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/ehjci\/jex133","article-title":"Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension.","volume":"19","author":"Gorter","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R16-20260407","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000501100","article-title":"Endothelin 1 is associated with heart failure hospitalization and long-term mortality in patients with heart failure with preserved ejection fraction and pulmonary hypertension.","volume":"143","author":"Chowdhury","year":"2019","journal-title":"Cardiology"},{"key":"R17-20260407","first-page":"400","article-title":"Left atrial diameter and atrial fibrillation, but not elevated NT-proBNP, predict the development of pulmonary hypertension in patients with HFpEF.","volume":"17","author":"Liu","year":"2020","journal-title":"J Geriatr Cardiol"},{"key":"R18-20260407","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/heartjnl-2022-321565","article-title":"Pulmonary hypertension with a precapillary component in heart failure with preserved ejection fraction.","volume":"109","author":"Sera","year":"2023","journal-title":"Heart"},{"key":"R19-20260407","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/CM9.0000000000002112","article-title":"Prevalence, risk factors, and survival associated with pulmonary hypertension and heart failure among patients with underlying coronary artery disease: a national prospective, multicenter registry study in China.","volume":"135","author":"Huang","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"R20-20260407","first-page":"1","article-title":"Right ventricular-vascular uncoupling predicts pulmonary hypertension in clinically diagnosed heart failure with preserved ejection fraction.","volume":"13","author":"Chen","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"R22-20260407","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.chest.2021.08.039","article-title":"Pulmonary hypertension in the context of heart failure with preserved ejection fraction.","volume":"160","author":"Inampudi","year":"2021","journal-title":"Chest"},{"key":"R23-20260407","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"key":"R24-20260407","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R26-20260407","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.jacc.2015.08.876","article-title":"Emergence of nonobstructive coronary artery disease: a woman\u2019s problem and need for change in definition on angiography.","volume":"66","author":"Pepine","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R27-20260407","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13293-020-00306-7","article-title":"Estrogen-related mechanisms in sex differences of hypertension and target organ damage.","volume":"11","author":"Sabbatini","year":"2020","journal-title":"Biol Sex Differ"},{"key":"R28-20260407","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/jcecho.jcecho_31_18","article-title":"Reference values of longitudinal systolic right and left ventricular function measured by M-mode echocardiography in healthy preterm and term neonates.","volume":"28","author":"Ghandi","year":"2018","journal-title":"J Cardiovasc Echogr"},{"key":"R29-20260407","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/jrms.jrms_350_24","article-title":"The tricuspid annular plane systolic excursion\/PASP ratio\u2019s accuracy and validity in assessing the right ventricular function: a narrative review.","volume":"29","author":"Sercelik","year":"2024","journal-title":"J Res Med Sci"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T20:02:13Z","timestamp":1775592133000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":26,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001235","relation":{},"ISSN":["1061-5377","1538-4683"],"issn-type":[{"value":"1061-5377","type":"print"},{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]}}}